Anti-ADAMTS13 antibodies, cancer (and cancer therapy), chronic inflammation, pregnancy, liver disease, and disseminated intravascular coagulation are all associated with acquired ADAMTS13 deficiencies. This evidence concerns the gene ADAMTS13 and Disseminated intravascular coagulation.